Skip to content

Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device

Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05096247
Enrollment
48
Registered
2021-10-27
Start date
2021-09-03
Completion date
2022-09-13
Last updated
2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wrinkle, Benign Pigmented Lesions, Benign Vascular Lesions

Brief summary

The intended use of the RF (radiofrequency) device used in this study is to assess the efficacy of the handpiece for the treatment of facial wrinkles. If the other device (Intense Pulsed Light) laser in this study is used, the intended use will be for the treatment of benign pigmented and/or vascular lesions.

Interventions

DEVICETempSure

This device is an RF device.

DEVICEIcon

This device works with IPL (Intense Pulsed Light) handpieces.

Sponsors

Cynosure, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

One site will enroll patients to be treated with the the RF device, and the other site will enroll patients to be treated with the RF device and the Intense Pulsed Light (IPL) laser.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* A healthy male or female 18 years of age or older. * Agrees to be treated with the TempSure device. * Understands and accepts obligation not to receive any other procedures on the treatment area through the length of the study. * Understands and accepts the obligation and is logistically able to be present for all visits. * Is willing to comply with all requirements of the study and sign the informed consent document.

Exclusion criteria

* Is pregnant or of childbearing potential and not using medically effective birth control, or has been pregnant in the last 3 months, currently breast feeding or planning a pregnancy during the study. * The subject has a cut, wound, or infected skin on the area to be treated. * The subject is on local, oral, or systemic anesthetic agents. * The subject has nerve insensitivity to heat in the treatment area. * The subject has any condition or is in a situation which in the investigators opinion may put the subject at significant risk, may confound study results or may interfere significantly with the subject's participation.

Design outcomes

Primary

MeasureTime frameDescription
Number of Subjects Who Noticed Improvement12 week follow upSubjects graded themselves on a scale ranging from Worsened to Very Much Improved at the follow up visit. The number of subjects who graded themselves as Improved was reported.

Countries

United States

Participant flow

Participants by arm

ArmCount
Treatment With RF Device
Subjects in this arm of the study will be treated with the radiofrequency device, and will receive up to 4 treatments on the face. TempSure: This device is an RF device.
13
Treatment With IPL and RF Device
Subjects treated in this arm of the study will receive 2 treatments with just the radiofrequency device and then 2 treatments with both the radiofrequency and the IPL laser. TempSure: This device is an RF device. Icon: This device works with IPL (Intense Pulsed Light) handpieces.
35
Total48

Baseline characteristics

CharacteristicTreatment With RF DeviceTreatment With IPL and RF DeviceTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants2 Participants3 Participants
Age, Categorical
Between 18 and 65 years
12 Participants33 Participants45 Participants
FitzPatrick Skin Type
Fitzpatrick Skin Type I
0 Participants3 Participants3 Participants
FitzPatrick Skin Type
Fitzpatrick Skin Type II
6 Participants11 Participants17 Participants
FitzPatrick Skin Type
Fitzpatrick Skin Type III
5 Participants20 Participants25 Participants
FitzPatrick Skin Type
Fitzpatrick Skin Type IV
2 Participants1 Participants3 Participants
FitzPatrick Skin Type
Fitzpatrick Skin Type V
0 Participants0 Participants0 Participants
FitzPatrick Skin Type
Fitzpatrick Skin Type VI
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Caucasian
12 Participants35 Participants47 Participants
Race/Ethnicity, Customized
Hispanic
1 Participants0 Participants1 Participants
Sex: Female, Male
Female
12 Participants32 Participants44 Participants
Sex: Female, Male
Male
1 Participants3 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 130 / 35
other
Total, other adverse events
13 / 135 / 35
serious
Total, serious adverse events
0 / 130 / 35

Outcome results

Primary

Number of Subjects Who Noticed Improvement

Subjects graded themselves on a scale ranging from Worsened to Very Much Improved at the follow up visit. The number of subjects who graded themselves as Improved was reported.

Time frame: 12 week follow up

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Treatment With RF DeviceNumber of Subjects Who Noticed Improvement10 Participants
Treatment With IPL and RF DeviceNumber of Subjects Who Noticed Improvement34 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026